Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 10.77 Billion JPY | 4.42% |
| 2023 | 10.25 Billion JPY | -8.37% |
| 2022 | 10.25 Billion JPY | -8.61% |
| 2021 | 10.18 Billion JPY | -6.08% |
| 2020 | 10.59 Billion JPY | 8.44% |
| 2019 | 10.01 Billion JPY | -16.09% |
| 2018 | 11.46 Billion JPY | 2.42% |
| 2017 | 11.85 Billion JPY | -2.44% |
| 2016 | 12.16 Billion JPY | -99.05% |
| 2015 | 11.21 Billion JPY | -3.95% |
| 2014 | 11.61 Billion JPY | 6.31% |
| 2013 | 11.08 Billion JPY | 1.75% |
| 2012 | 10.89 Billion JPY | 0.34% |
| 2011 | 10.85 Billion JPY | 3.25% |
| 2010 | 10.51 Billion JPY | -0.67% |
| 2009 | 10.58 Billion JPY | 5.18% |
| 2008 | 10.06 Billion JPY | 10.87% |
| 2007 | 9.07 Billion JPY | 3.69% |
| 2006 | 8.75 Billion JPY | 8.75% |
| 2005 | 8.05 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 2.32 Billion JPY | -16.37% |
| 2024 FY | - JPY | 13864.55% |
| 2024 Q1 | 20.36 Million JPY | 20.1% |
| 2024 Q2 | 18.27 Million JPY | -99.38% |
| 2024 Q3 | 19.7 Million JPY | 15111.33% |
| 2023 Q4 | 18.42 Million JPY | -13.09% |
| 2023 Q1 | 20.33 Million JPY | 4.16% |
| 2023 FY | - JPY | -8.37% |
| 2023 Q3 | 21.2 Million JPY | 35.77% |
| 2023 Q2 | 15.61 Million JPY | -23.22% |
| 2022 Q4 | 19.52 Million JPY | -21.06% |
| 2022 Q3 | 24.73 Million JPY | 9.09% |
| 2022 FY | - JPY | -8.61% |
| 2022 Q1 | 22.54 Million JPY | -99.01% |
| 2022 Q2 | 22.67 Million JPY | 0.59% |
| 2021 Q2 | 2.68 Billion JPY | 13.62% |
| 2021 Q1 | 2.36 Billion JPY | -52.96% |
| 2021 Q3 | 3.27 Billion JPY | 21.74% |
| 2021 FY | - JPY | -6.08% |
| 2021 Q4 | 2.28 Billion JPY | -30.28% |
| 2020 Q3 | 2.82 Billion JPY | 357.7% |
| 2020 FY | - JPY | 8.44% |
| 2020 Q1 | 2.62 Billion JPY | 36.04% |
| 2020 Q4 | 5.02 Billion JPY | 77.94% |
| 2020 Q2 | 617 Million JPY | -76.51% |
| 2019 FY | - JPY | -16.09% |
| 2019 Q1 | 2.59 Billion JPY | -0.23% |
| 2019 Q2 | -1.4 Billion JPY | -154.01% |
| 2019 Q3 | 2.91 Billion JPY | 308.2% |
| 2019 Q4 | 1.93 Billion JPY | -33.85% |
| 2018 Q4 | 2.6 Billion JPY | -12.74% |
| 2018 Q3 | 2.98 Billion JPY | 3.47% |
| 2018 Q2 | 2.88 Billion JPY | 223.46% |
| 2018 Q1 | 891 Million JPY | -67.86% |
| 2018 FY | - JPY | 2.42% |
| 2017 FY | - JPY | -2.44% |
| 2017 Q2 | 2.97 Billion JPY | -2.84% |
| 2017 Q1 | 3.06 Billion JPY | -7.93% |
| 2017 Q3 | 2.02 Billion JPY | -32.0% |
| 2017 Q4 | 2.77 Billion JPY | 36.89% |
| 2016 Q2 | 3.01 Billion JPY | 6.51% |
| 2016 FY | - JPY | -99.05% |
| 2016 Q3 | 3.1 Billion JPY | 3.16% |
| 2016 Q4 | 3.32 Billion JPY | 7.18% |
| 2016 Q1 | 2.82 Billion JPY | -1.74% |
| 2015 Q2 | 2.69 Billion JPY | 1.85% |
| 2015 Q1 | 2.64 Billion JPY | -7.91% |
| 2015 Q3 | 3.1 Billion JPY | 15.42% |
| 2015 FY | - JPY | -3.95% |
| 2015 Q4 | 2.87 Billion JPY | -7.4% |
| 2014 Q4 | 2.87 Billion JPY | -10.31% |
| 2014 FY | - JPY | 6.31% |
| 2014 Q3 | 3.2 Billion JPY | 9.29% |
| 2014 Q2 | 2.92 Billion JPY | 5.06% |
| 2014 Q1 | 2.78 Billion JPY | 14.74% |
| 2013 FY | - JPY | 1.75% |
| 2013 Q3 | 3.22 Billion JPY | 18.44% |
| 2013 Q4 | 2.42 Billion JPY | -24.68% |
| 2013 Q1 | 2.7 Billion JPY | 8.97% |
| 2013 Q2 | 2.72 Billion JPY | 0.55% |
| 2012 Q3 | 2.98 Billion JPY | 15.55% |
| 2012 FY | - JPY | 0.34% |
| 2012 Q1 | 2.83 Billion JPY | 12.85% |
| 2012 Q4 | 2.48 Billion JPY | -16.81% |
| 2012 Q2 | 2.58 Billion JPY | -8.88% |
| 2011 Q2 | 2.63 Billion JPY | -2.26% |
| 2011 Q3 | 3 Billion JPY | 13.87% |
| 2011 FY | - JPY | 3.25% |
| 2011 Q1 | 2.69 Billion JPY | 10.84% |
| 2011 Q4 | 2.51 Billion JPY | -16.31% |
| 2010 Q1 | 2.6 Billion JPY | 2.11% |
| 2010 Q3 | 2.86 Billion JPY | 9.7% |
| 2010 Q2 | 2.6 Billion JPY | 0.15% |
| 2010 FY | - JPY | -0.67% |
| 2010 Q4 | 2.43 Billion JPY | -14.92% |
| 2009 Q2 | 2.06 Billion JPY | 0.0% |
| 2009 FY | - JPY | 5.18% |
| 2009 Q3 | 2.95 Billion JPY | 43.36% |
| 2009 Q4 | 2.55 Billion JPY | -13.7% |
| 2008 FY | - JPY | 10.87% |
| 2007 FY | - JPY | 3.69% |
| 2006 FY | - JPY | 8.75% |
| 2005 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 1117995.667% |
| Ansell Limited | 209.86 Million USD | -5034.82% |
| Ansell Limited | 206.3 Million USD | -5123.461% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -25054.178% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 663258.458% |
| Psykey, Inc. | -1.29 Million USD | 832028.258% |
| ConvaTec Group Plc | 455.5 Million USD | -2265.752% |
| ConvaTec Group Plc | 455.5 Million USD | -2265.752% |
| Encision Inc. | -544.19 Thousand USD | 1980272.548% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 7598999.937% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 9802701.656% |
| Innovative MedTech Inc. | -7.67 Million USD | 140525.554% |
| LifePoint, Inc. | -14.2 Million USD | 75975.905% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 174271.65% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 3315792.308% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 5006743.932% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 2655700.024% |
| SmileDirectClub, Inc. | -186.13 Million USD | 5889.222% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -2306.3% |
| SheerVision, Inc. | -110.53 Thousand USD | 9749401.101% |
| United Health Products, Inc. | -2.5 Million USD | 430758.609% |
| Vasamed, Inc. | -4.57 Million USD | 235669.715% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 476758.929% |
| Yubo International Biotech Limited | -1.17 Million USD | 915114.698% |